Vpu exerts a positive effect on HIV-1 infectivity by down-modulating CD4 receptor molecules at the surface of HIV-1-producing cells - PubMed (original) (raw)
. 2003 Jul 25;278(30):28346-53.
doi: 10.1074/jbc.M300327200. Epub 2003 May 13.
Affiliations
- PMID: 12746459
- DOI: 10.1074/jbc.M300327200
Free article
Vpu exerts a positive effect on HIV-1 infectivity by down-modulating CD4 receptor molecules at the surface of HIV-1-producing cells
Karine Levesque et al. J Biol Chem. 2003.
Free article
Abstract
Human immunodeficiencey virus, type 1 (HIV-1) encodes three proteins, Nef, Vpu, and gp160, that down-modulate surface expression of the CD4 receptor during viral infection. In the present study, we have investigated the role of CD4 down-modulation in the HIV-1 infection cycle, primarily from the perspective of Vpu function. We report here that, like Nef, Vpu-mediated CD4 degradation modulates positively HIV-1 infectivity. Our data reveal that accumulation of CD4 at the cell surface of Vpu-deficient HIV-1-producing cells leads to an efficient recruitment of CD4 into virions and to an impairment of viral infectivity. This CD4-mediated inhibition of viral infectivity was not observed when a CD4 mutant unable to bind Env gp120 was used or when VSV-G glycoprotein was utilized to pseudotype viruses, suggesting that an interaction between CD4 and gp120 is required for interference. Indeed, protein analysis of Vpu-defective viral particles reveals that CD4 recruitment is associated with an increased formation of gp120-CD4 complexes at the virion surface. Interestingly, we did not detect any difference at the level of total virion-associated Env glycoproteins between wild-type and Vpu-defective virus, indicating that accumulation of CD4 at the cell surface and recruitment of CD4 into Vpu-defective HIV-1 particles exert a negative effect on viral infectivity, most likely by promoting the formation of nonfunctional gp120-CD4 complexes at the virion surface. Finally, we show that both Vpu- and Nef-induced CD4 down-modulation activities are required for production of fully infectious particles in CD4+ T cell lines and primary cells, an observation that has clear implications for viral spread in vivo.
Similar articles
- Enhanced CD4 down-modulation by late stage HIV-1 nef alleles is associated with increased Env incorporation and viral replication.
Argañaraz ER, Schindler M, Kirchhoff F, Cortes MJ, Lama J. Argañaraz ER, et al. J Biol Chem. 2003 Sep 5;278(36):33912-9. doi: 10.1074/jbc.M303679200. Epub 2003 Jun 19. J Biol Chem. 2003. PMID: 12816953 - Downregulation of CD4 is required for maintenance of viral infectivity of HIV-1.
Tanaka M, Ueno T, Nakahara T, Sasaki K, Ishimoto A, Sakai H. Tanaka M, et al. Virology. 2003 Jul 5;311(2):316-25. doi: 10.1016/s0042-6822(03)00126-0. Virology. 2003. PMID: 12842621 - Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner.
Lama J, Mangasarian A, Trono D. Lama J, et al. Curr Biol. 1999 Jun 17;9(12):622-31. doi: 10.1016/s0960-9822(99)80284-x. Curr Biol. 1999. PMID: 10375528 - [Mechanisms of reduction of CD4 receptor expression on the surface of HIV-1 infected cells].
Geleziunas R, Morin N, Wainberg MA. Geleziunas R, et al. C R Acad Sci III. 1996 Aug;319(8):653-62. C R Acad Sci III. 1996. PMID: 8949388 Review. French. - Role of CD4 receptor down-regulation during HIV-1 infection.
Levesque K, Finzi A, Binette J, Cohen EA. Levesque K, et al. Curr HIV Res. 2004 Jan;2(1):51-9. doi: 10.2174/1570162043485086. Curr HIV Res. 2004. PMID: 15053340 Review.
Cited by
- Inhibition of human immunodeficiency virus (HIV-1) infectivity by expression of poorly or broadly neutralizing antibodies against Env in virus-producing cells.
Wang Q, Zhang S, Nguyen HT, Sodroski J. Wang Q, et al. J Virol. 2024 Feb 20;98(2):e0159423. doi: 10.1128/jvi.01594-23. Epub 2024 Jan 30. J Virol. 2024. PMID: 38289101 Free PMC article. - Differential Ability of Spike Protein of SARS-CoV-2 Variants to Downregulate ACE2.
Maeda Y, Toyoda M, Kuwata T, Terasawa H, Tokugawa U, Monde K, Sawa T, Ueno T, Matsushita S. Maeda Y, et al. Int J Mol Sci. 2024 Jan 22;25(2):1353. doi: 10.3390/ijms25021353. Int J Mol Sci. 2024. PMID: 38279353 Free PMC article. - Characterization of the Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Conformational States on Infectious Virus Particles.
Nguyen HT, Wang Q, Anang S, Sodroski JG. Nguyen HT, et al. J Virol. 2023 Mar 30;97(3):e0185722. doi: 10.1128/jvi.01857-22. Epub 2023 Feb 23. J Virol. 2023. PMID: 36815832 Free PMC article. - HIV-1 Vpu restricts Fc-mediated effector functions in vivo.
Prévost J, Anand SP, Rajashekar JK, Zhu L, Richard J, Goyette G, Medjahed H, Gendron-Lepage G, Chen HC, Chen Y, Horwitz JA, Grunst MW, Zolla-Pazner S, Haynes BF, Burton DR, Flavell RA, Kirchhoff F, Hahn BH, Smith AB 3rd, Pazgier M, Nussenzweig MC, Kumar P, Finzi A. Prévost J, et al. Cell Rep. 2022 Nov 8;41(6):111624. doi: 10.1016/j.celrep.2022.111624. Cell Rep. 2022. PMID: 36351384 Free PMC article. - A pilot study to show that asymptomatic sexually transmitted infections alter the foreskin epithelial proteome.
Chigorimbo-Murefu NTL, Potgieter M, Dzanibe S, Gabazana Z, Buri G, Chawla A, Nleya B, Olivier AJ, Harryparsad R, Calder B, Garnett S, Maziya L, Lewis DA, Jaspan H, Wilson D, Passmore JS, Mulder N, Blackburn J, Bekker LG, Gray CM. Chigorimbo-Murefu NTL, et al. Front Microbiol. 2022 Oct 17;13:928317. doi: 10.3389/fmicb.2022.928317. eCollection 2022. Front Microbiol. 2022. PMID: 36325020 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials